Tabuk Pharmaceuticals Manufacturing Company-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013212
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products . The company offers products in various therapeutic areas including alimentary tract and metabolism, antineoplastic and immuno-modulators, blood and blood forming organs, cardiovascular system, systemic anti infective, dermatologicals, genito-urinary system and sex hormones, multivitamin, musculo skeletal, nervous system, parasitology, respiratory system and others. It collaborates with other pharmaceutical companies to enhance its portfolio of medicines. The company has a presence in Middle East and North Africa regions. Tabuk is headquartered in Riyadh, Saudi Arabia.

Tabuk Pharmaceuticals Manufacturing Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 10
Licensing Agreements 11
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 11
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 12
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 13
Tabuk Pharma Enters into Licensing Agreement with Aenova 14
Tabuk Pharma Enters into Licensing Agreement with Pfizer 15
Asset Transactions 16
Acino Pharma Acquires Three Products from Tabuk Pharma 16
Tabuk Pharmaceuticals Manufacturing Company – Key Competitors 17
Tabuk Pharmaceuticals Manufacturing Company – Key Employees 18
Tabuk Pharmaceuticals Manufacturing Company – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Key Facts 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tabuk Pharmaceuticals Manufacturing Company, Deals By Therapy Area, 2011 to YTD 2017 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tabuk Pharma Enters into Distribution Agreement with Genetic 10
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 11
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 12
Innovus Pharma Entes into Licensing Agreement with Tabuk Pharma 13
Tabuk Pharma Enters into Licensing Agreement with Aenova 14
Tabuk Pharma Enters into Licensing Agreement with Pfizer 15
Acino Pharma Acquires Three Products from Tabuk Pharma 16
Tabuk Pharmaceuticals Manufacturing Company, Key Competitors 17
Tabuk Pharmaceuticals Manufacturing Company, Key Employees 18
Tabuk Pharmaceuticals Manufacturing Company, Other Locations 19

★海外企業調査レポート[Tabuk Pharmaceuticals Manufacturing Company-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RPC Group Plc (RPC):企業の財務・戦略的SWOT分析
    RPC Group Plc (RPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Multan Electric Power Co Ltd:企業の戦略的SWOT分析
    Multan Electric Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Brady Corporation:企業の戦略・SWOT・財務分析
    Brady Corporation - Strategy, SWOT and Corporate Finance Report Summary Brady Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Idorsia Pharmaceutical Ltd (IDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idorsia Pharmaceutical Ltd (Idorsia) is a manufacturer and developer of medicine that discovers, develops various therapies. The company provides pipeline portfolio such as investigational candidates targeted at the treatment of resistant hypertension, chronic insomnia, vasospasm, and system …
  • Fred’s, Inc.:戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The InterTech Group Inc:企業の戦略的SWOT分析
    The InterTech Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Sciessent LLC:企業の戦略的SWOT分析
    Sciessent LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • L-3 Unmanned Systems, Inc.:企業の戦略・SWOT・財務分析
    L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PulteGroup, Inc.:企業の戦略・SWOT・財務情報
    PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Baytex Energy Corp (BTE):企業の財務・戦略的SWOT分析
    Baytex Energy Corp (BTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dundee Precious Metals Inc.:企業の戦略・SWOT・財務情報
    Dundee Precious Metals Inc. - Strategy, SWOT and Corporate Finance Report Summary Dundee Precious Metals Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sociedad Minera El Brocal SAA (BROCALC1):企業の財務・戦略的SWOT分析
    Sociedad Minera El Brocal SAA (BROCALC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Leonardo DRS Inc:企業の戦略的SWOT分析
    Leonardo DRS Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Puget Sound Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Puget Sound Energy Inc (PSE), a subsidiary of Puget Energy Inc, is a utility service provider. The company offers offers services such as energy and natural gas supply, start service, power outages, natural gas safety, business services, natural gas storage and excess generation of energy. I …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務分析
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆